✦ LIBER ✦

FasL gene therapy: a new therapeutic modality for head and neck cancer

✍ Scribed by El-Zawahry, A M; Holman, D H; Liu, X; Schwartz, D A; Day, T A; Dong, J-Y; Norris, J S; ElOjeimy, S; McKillop, J C

Book ID: 110019351
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 398 KB
Volume: 13
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700951

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene therapy for head and neck cancer

✍ Dr. Gary L. Clayman 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 733 KB

Background. Molecular or gene therapy involves the introduction of genetic material (DNA) into host cells to induce the expression of the therapeutic product of that gene. This ability to transfer genetic material provides a novel approach for the investigation and potential treatment of a variety o

Optimizing Suicide Gene Therapy for Head

Optimizing Suicide Gene Therapy for Head and Neck Cancer

✍ Duane A. Sewell; Daqing Li; Ling Duan; Mary R. Schwartz; Bert W. O'Malley Jr 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Combination Nonviral Cytokine Gene Thera

Combination Nonviral Cytokine Gene Therapy for Head and Neck Cancer

✍ Daqing Li; Jacob W. Zeiders; Shixi Liu; Ming Guo; Yun Xu; Jeffrey S. Bishop; Ber 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Personalized peptide vaccines: A new the

Personalized peptide vaccines: A new therapeutic modality for cancer

✍ Kyogo Itoh; Akira Yamada 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

Alloantigen gene therapy for head and ne

Alloantigen gene therapy for head and neck cancer: Evaluation of animal models

✍ Lyon L. Gleich; Ya-Qin Li; Shunan Li; Jack L. Gluckman; Peter J. Stambrook 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Background: Human trials of alloantigen gene therapy, using the class i major histocompatibility complex (mhc) hla-b7, have demonstrated the potential efficacy of this treatment for head and neck cancer. its mechanism remains unclear. an immune-competent mouse model of mhc gene therapy to test f

m-THPC photodynamic therapy for head and

m-THPC photodynamic therapy for head and neck cancer

✍ M. G. Dilkes; M. L. DeJode; A. Rowntree-Taylor; J. A. McGilligan; G. S. Kenyon; 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 608 KB